Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| DHEA (Dehydroepiandrosterone) | Melatonin | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 25-50mg daily (men); 10-25mg daily (women) | 0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision) |
| Timing | Morning (mimics natural circadian peak). With food. | 30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking. |
| Cycle Duration | Ongoing under supervision with regular blood monitoring (DHEA-S, testosterone, estradiol, PSA in men) | Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision |
| Evidence Level | moderate_human | strong_human |
DHEA is the most abundant circulating steroid hormone, produced primarily by the adrenal zona reticularis. It serves as a precursor for both androgens (testosterone, DHT via 3beta-HSD and 17beta-HSD) and estrogens (estradiol, estrone via aromatase). DHEA-S (sulfated form) acts as a neurosteroid, positively modulating NMDA receptors and antagonizing GABA-A receptors (cognitive enhancement/alertness). It also modulates immune function (enhances Th1 immunity, IL-2 production), supports bone mineral density via estrogenic metabolites, enhances insulin sensitivity via PPAR-alpha activation, and opposes cortisol's catabolic effects (DHEA:cortisol ratio is a stress/aging biomarker).
25-50mg daily (men); 10-25mg daily (women)
Morning (mimics natural circadian peak). With food.
Ongoing under supervision with regular blood monitoring (DHEA-S, testosterone, estradiol, PSA in men)
Melatonin (N-acetyl-5-methoxytryptamine) is synthesized from serotonin in the pineal gland, regulated by the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract. It binds MT1 and MT2 G-protein coupled receptors: MT1 activation suppresses neuronal firing in the SCN (sleep onset), while MT2 modulates circadian phase shifting. Beyond sleep, melatonin is a potent antioxidant that scavenges hydroxyl radicals, peroxynitrite, and singlet oxygen, and upregulates antioxidant enzymes (GPx, SOD, catalase) via Nrf2. It has anti-inflammatory properties (NF-kB suppression), immunomodulatory effects, oncostatic activity (anti-proliferative in several cancer types), and mitochondrial protective functions.
0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision)
30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking.
Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →